August 16, 2000

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

The LV5FU2-oxaliplatin combination seems beneficial as first-line therapy in advanced colorectal cancer, demonstrating a prolonged progression-free survival with acceptable tolerability and maintenance of QoL.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Gramont et al. (Wed,) studied this question.

synapsesocial.com/papers/69d7cd4e319e71454dbedabb — DOI: https://doi.org/10.1200/jco.2000.18.16.2938

Authors

Aimery de Gramont

Institut Hospitalier Franco Britannique

Arié Figer

Ontario Institute for Cancer Research

Michel Seymour

University of Leeds

Journals

Journal of Clinical Oncology

Actions

Institutions

Fondazione IRCCS Istituto Nazionale dei Tumori

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion